Improving cancer patients' prognosis by incorporating mindfulness intervention into the treatment strategy.

This letter discusses the study by Liu recently published in , which examines the benefits of combining epirubicin (EPI) with mindfulness interventions for patients with urinary system tumors and depression. The study included 110 patients and compared an experimental group receiving EPI and a mindfulness intervention strategy with a control group treated with mitomycin and standard care. Results showed that the experimental group had significant improvements in immune function, tumor markers, depression severity, quality of life, cancer-related fatigue, and nursing satisfaction. Despite acknowledging the study limitations such as a relatively small sample size and a short duration, the study highlights the efficacy of integrating mindfulness interventions into cancer treatment strategies to enhance patient outcomes and address psychological distress.